Thursday, November 30, 2006

Students at NTUST
Topic Presentation on Dec. 1
Presenter: Hank (A9517527) and Elton (A9517531)
TOPIC:New Spirit —LOHAS—Needed for us, our society and Planet

Outline
1. Introduction
2. What is LOHAS?
3. Ways to approach LOHAS
4. LOHAS in our life
5. How LOHAS are you?
6. Conclusion
7. Reference
8. Q and A time

What is LOHAS?
Lifestyles of Health and Sustainability
Balance, Responsibility and Respect

Ways to approach LOHAS
Simplicity
Simple life is not simple.
It is about living an examined life.
Radically changing ecological, social, and psycho-spiritual circumstances of the modern world

Choiceful Simplicity:
Choose our path through life consciously, deliberately, and of our own accord.

Commercial Simplicity:
There is a rapidly growing market for healthy and sustainable products and services of all kinds -- from home-building materials and energy systems to foods.

Ecological Simplicity:
Choose ways of living that touch the Earth more lightly and that reduce our ecological footprint.

Elegant Simplicity:
The way we live our lives represents a work of unfolding artistry.

An elegant simplicity is an organic aesthetic that contrasts with the excess of consumerist lifestyles.
Frugal Simplicity:
By cutting back on spending that is not truly serving our lives, and by practicing skillful management of our personal finances, we can achieve greater financial independence.

Political Simplicity:
Organizing our collective lives in ways that enable us to live more lightly and sustainably on the Earth which involves changes in nearly every area of public life -- from transportation and education to the design of our homes, cities, and workplaces.

Soulful Simplicity:
To approach life as a meditation.

How possible the concept of LOHAS be applied in many aspects of our lives. Sustainable Economy: Green building and industrial goods, Renewable energy, Resource-efficient products, Socially responsible investing, Alternative transportation, Environmental management Alternative Healthcare: Health and wellness solutions, etc. Holistic disease prevention, Complementary medicine Healthy Lifestyles: Natural, organics; nutritional products, Food and beverage, Dietary supplements, Personal care. Personal Development: Mind, body and spirit products such as CDs, books, tapes, seminars Yoga, fitness, weight loss, Spiritual products and services Ecological Lifestyles: Ecological home and office products - Organic / recycled fiber products, - Environmentally friendly appliances, - Eco-tourism and travel

How Lohas are you?
Take this quiz to find out whether you're living LOHAS. Answer the questions, then add your points to see which segment you're in.

1 = Rarely 2 = Sometimes 3 = Usually

• 1, 2 or 3 - I care about maintaining excellent physical health.
• 1, 2 or 3 - I care about protecting the environment.
• 1, 2 or 3 - I care about sustainable agricultural practices.
• 1, 2 or 3 - I care about using renewable energy sources.
• 1, 2 or 3 - I tell family and friends about the benefits of purchasing
environmentally friendly products.
• 1, 2 or 3 - I care about women's issues.
• 1, 2 or 3 - I care about social consciousness.
• 1, 2 or 3 - I prefer to buy products from companies whose values are like
mine.
• 1, 2 or 3 - I like choosing environmentally friendly products and services.
• 1, 2 or 3 - I'm willing to pay 20 percent more for environmentally friendly
products.

• You’re a LOHAS. You care deeply about the environment and society, and you act on those behaviors. You likely buy a lot of organic foods, drive a fuel-efficient car and live in an eco-friendly home. People look to you for advice and information on the environment and society.

• You’re a NOMADIC. You care about some of these issues but not all of them all of the time. You take action in some parts of your life but have not totally adopted a LOHAS lifestyle.
You're a CENTRIST. You are slightly more conservative than your LOHAS and NOMADIC peers. While some of these behaviors and ideas appeal to you, they are not top priorities in your life.

You're an INDIFFERENT. You are committed to other immediate concerns in your life and don't think a great deal about the quality of the environment and society.

Wednesday, November 22, 2006

Reading Presentation 8 No. 10~18 on 12/15
Select one of the articles from the websites and talk about it.
http://www.world-mysteries.com/
http://www.world-mysteries.com/hvd_sexdrive_1.htm
http://www.world-mysteries.com/sci_16.htm

*********************************************************

Topic Presentation 9 No 32~41 A9317501 on 12/22
work in groups to research
Option 1
prepare a poster presentation on another unexplained phenomenon, including at least two possible explanations that have been proposed from the papers.
Option 2
find a suitable video clip or a segment about a mysterious event. In it , you need to point out an eyewintness and offer experts' theories about what happened.

Tuesday, November 21, 2006

Avid consumers, or just crazy?
A recent study may actually lead to a medical diagnosis for over-compulsive shoppers.October 28, 2006 AuthorMeghan DaumThe New Yorker, Harper's, and Vogue. Her essays are taught in many college classrooms. Meghan has taught nonfiction writing at New York University.www.meghandaum.com. Topic/SectionsIntroductionA recent study about compulsive buying, led by Dr. Lorrin Koran, emeritus professor of psychiatryMeghan’s point of viewThe root of the problemConclusionIntroductionHow often have you felt others would be horrified if they knew of your spending habits? How often have you bought things even though you couldn't afford them? If you have any money left at the end of a pay period, do you have to spend it? The StudyCompulsive shopping is an impulse-control disorder rather than a failure of will. "People talk about the excitement they get from being in the mall. It's a way of escaping negative emotions." “Once these shoppers buy something, they're not interested in it anymore. Generally only about 10% bother to return what they bought.“They were almost as likely to be male as female. (Binge shopping — an equal opportunity vice!) Main IdeaDo we need to pathologize something whose cure might be as simple as avoiding the mall or watching "South Park" instead of the Home Shopping Network? (Although Kenny's orange parka is pretty awesome; why not buy one just like it?)
Supporting IdeaIn the last six months, I have been meaning to return two pairs of shoes, a really ugly handbag that looked much better in its online photo. Also, I don't always pay my full credit card balance, I've bought things I cannot afford and, at times, I would have been horrified if others knew about my purchasing habits. But, let's be clear, that's not because I escape negative emotions by going shopping. Supporting IdeaIf anything, stepping just one foot into a mall puts me well within the range of Diagnosis Code 300.21: panic attack with agoraphobia … So I buy stuff online. Even stuff like socks. That sometimes means spending more money on shipping than on the item itself, but, for me, it's well worth not having to walk past a Sunglass Hut. ConclusionMore of us may have excessive shopping problems than was previously thought, but it's also easier to shop than ever before. I spend upward of six hours a day in perilous proximity to the biggest mall in the world, the one inside my computer. ... And although Koran says most truly compulsive buyers tend not to shop online, what's to say a clinical diagnosis, courtesy of shopping.com, might not lie in all of our futures?

By Ethan & Garfie

Wednesday, November 08, 2006

http://adbusters.org/home/

Reading Presentation 6
No. 19~26 on 11/24
Group in 2 no more than 3
Find some publications print letters to the editor. (op-ed opposite editorial page or editorials )

eg:http://select.nytimes.com/pages/timesselect/index.html

http://www.usatoday.com/news/opinion/editorials/2005-11-29-wikipedia-edit_x.htm

http://www.washtimes.com/op-ed/20061107-083643-4008r.htm

You are not required to use the above articles. They are just some examples. Feel free to find something that you think it is interesting.
What was the topic? Bring and present an English-language publication and read some of the letter to the class.
Point out if the letter to the editor is clearly written.
Is there a topic sentence that gives the main idea?
Find out some supporting ideas in the letter.
**************************************************************************
Topic Presentation 7
12/1 No 24~31
Work in group of 3 to research and give a presentation on the work of another visionary who “thinks outside the box.”

Sunday, November 05, 2006

Birth Order and Personality
Presented By
Ethan, Cindy, & Stanley
Does Birth Order Determine Personality?
Yes!
Introduction
Evolutionary Theory

Evolutionary Theory
Siblings compete for …



First Born Children
Extroverted and confident
Assertive, authoritarian, dominant, inflexible
Conformist, politically conservative
Defensive about errors and mistakes

Famous First Born
Hard-working
Ebullient
Focused
Passionate
Sincere
Dynamic

Famous First Born
Task -oriented, conscientious and disciplined
Concerned about and fearful of losing position and rank

Second Born Children
Open to new experiences
Rebellious
Unconventional
More likely to embrace change and innovation



Famous Second Born
Communicative
Creative
Flexible
Middle Children
Diplomatic and politically skilled
Good at negotiation, peacemaking, and compromise
Relatively closer to friends than to family

Famous Middle Born
“Expect change to be the norm”
“Do not accept the status quo as good and enough”
“Allergic to hierarchy”
Famous Middle Born
Diplomatic skills
Adaptable to change



Only Children
More conform to
parental expectations
Good students
Independent



Famous Only Child
Twins
Closer relations
Less conflict
More similar in personality

Famous Twins
Jamie Dimon,
CEO of JP Morgan Chase





Special Circumstances
Other variables, such as:
Culture
Socioeconomic factors
Family size
Attributes of parents
Divorce, additional marriages, and half- or step- siblings



Conclusion
Reference
 Kate Lorenz. “Does Birth Order Determine Success?” CareerBuilder.com Editor.
Dr. Kevin Leman. “Birth order factor and your personality”
Henry T. Stein, Ph.D. “Adlerian Overview of Birth Order Characteristic”


Question Time
Q. What is “Siblings” ?
Brothers & sisters
Q. Who is more assertive and dominate?
First born children
Q. Who is more open to accept new experiences?
Second born children
Q. Who is more likely to have the same personality with their siblings?
Twins

Friday, November 03, 2006

A Database for Disease
A genetic "roadmap" will help to find treatments for diseases, by looking at the signatures that drugs leave behind.
By Corinna Wu
A newly developed genetic "roadmap" promises to streamline the drug discovery process. Called the Connectivity Map, this public database matches drug compounds with diseased cells and the processes occurring within them.
"The reason it's so difficult to find those disease and drug connections is that the languages in which they are conventionally described are very different," says Justin Lamb, senior scientist at the Broad Institute in Cambridge, MA. "A physician would describe a disease in terms of its physical symptoms, whereas a chemist would describe drug actions in terms of binding that chemical to a particular protein." The researchers want to bridge that gap using a common language: gene-_expression signatures.
At any point in time, some genes in a cell are expressed, or "on", while others are not. And a cell's particular profile of activity is known as its gene-_expression signature. When cells are exposed to a drug, that signature changes: some genes that were expressed are turned off and vice-versa. And different drugs leave different signatures. It is these signatures that the researchers used to build the Connectivity Map.
Lamb and his colleagues conducted a pilot study on a select number of compounds and cell types to create the first installment of the map, reported recently in the journal Science. They chose 164 molecules that were biologically active, including drugs approved by the FDA and compounds commonly used as tools in the lab. They tested the molecules on four types of cancer cells--breast cancer, prostate cancer, leukemia, and melanoma--looking at how the compounds affected gene _expression in those cells.
The researchers did the analysis using DNA microarrays made by the company Affymetrix. These tiny glass chips are coated with thousands of short sequences of DNA that refer to parts of the human genome that often differ between individuals. For a given drug or cell type, the chips produce a unique pattern corresponding to the particular genes expressed. For example, the hormone estrogen might cause breast cancer cells to express certain genes, but have no effect in a prostate cancer cell, and that difference would be visible on the DNA chip.
The researchers then developed a computer program to compare the signatures to each other and rate the strength of the connections. The data from even this relatively small number of cell types and compounds, Lamb says, has yielded two new findings, described in papers in the journal Cancer Cell.
One compound, a plant-derivative called gedunin, was identified through a conventional screening method as interfering with the hormone androgen in prostate cancer cells, which is an important strategy in treating the disease. But the exact mechanism of how gedunin blocked the androgen signaling pathway wasn't clear. When the scientists searched the Connectivity Map for compounds that had similar activity to gedunin, though, they found matches to compounds that inhibit heat shock proteins and thus suppress androgen receptor activity.
The other finding involved a specific type of leukemia that was resistant to traditional chemotherapy. A team led by Scott Armstrong, an assistant professor at Harvard Medical School and Children's Hospital in Boston, determined the signature of the drug-resistant cells, queried the Connectivity Map, and found a match to sirolimus, a drug currently used to prevent rejection after organ transplantation. When they tested the drug in the lab, the scientists found that it re-sensitized the leukemia cells to chemotherapy, reversing the drug resistance.
"That was a particularly gratifying example for all of us," Lamb says, "because sirolimus is already FDA-approved for another indication. That means that this compound is known to be safe and tolerated by humans, and the path to clinical evaluation of sirolimus can probably be tested in the clinic much more quickly."
The team plans to expand the map to cover all 1,400 or so drugs approved by the FDA, an effort that should take between one and two years. "We wanted to make data that was broadly useful, so that requires a systematic approach to data generation," Lamb says. "And then if you can make that database accessible to the world in a way which is easy for the world to interact with it, that would solve a lot of problems for a lot of people."
The work done by the Broad scientists "is right on target," says Gregory Riggins, associate professor of neurosurgery, oncology, and genetic medicine at Johns Hopkins University. "This kind of group effort and approach is therapeutic-directed and is what is needed from the research community."
Copyright Technology Review 2006.